Bristol-Myers Squibb (NYSE:BMY) Receives Average Recommendation of “Hold” from Brokerages
Bristol-Myers Squibb (NYSE:BMY – Get Free Report) has earned an average recommendation of “Hold” from the twenty-one ratings firms that are presently covering the stock, Marketbeat Ratings reports.
Zacks Research Issues Pessimistic Outlook for BMY Earnings
Analysts at Zacks Research cut their Q1 2025 EPS estimates for Bristol-Myers Squibb in a research report issued on Wednesday, January 29th. Zacks Research analyst E. Bagri now forecasts that the ...
No One Knows How to Price AI Tools
More than two years after the public debut of ChatGPT, software companies still haven’t found a compelling way of charging ...
The Armenian Reporter20h
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Sonora Investment Management Group LLC
Sonora Investment Management Group LLC cut its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 21.6% during the 4th quarter, according to its most recent Form 13F filing with the ...
Budget 2025: Cancer Care, Rare Diseases, Heart Attack Prevention Drugs On 'Lifesaving' List Now
The list of 36 drugs, which are exempt from basic customs duty, includes many expensive and imported medicines that can ...